Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Poseida Therapeutics is a clinical-stage biopharmaceutical company specializing in cell and gene therapies for cancer and rare diseases. Its proprietary platforms enable the development of off-the-shelf CAR-T and gene therapy products with enhanced safety, durability, and manufacturing efficiency. Focused on solid tumors and hematological malignancies, the company leverages advanced gene editing, gene insertion, and delivery technologies to create innovative, scalable treatments aimed at improving efficacy and accessibility.
This description was generated via AI from an annual report. Updated about 1 year ago.